How were Patheon N.V. Ordinary shares, p's earnings last quarter?

Patheon N.V. Ordinary shares, p (NYSE:PTHN) announced its earnings results on Thursday, June, 8th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.01. The company had revenue of $483.40 million for the quarter, compared to the consensus estimate of $466.08 million. The firm's quarterly revenue was up 3.2% on a year-over-year basis.

What other stocks do shareholders of Patheon N.V. Ordinary shares, p own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Patheon N.V. Ordinary shares, p investors own include SVB Financial Group (SIVB) , Skyworks Solutions (SWKS) , Wells Fargo & Company (WFC) , Alexion Pharmaceuticals (ALXN) , NXP Semiconductors (NXPI) , Bank of the Ozarks (OZRK) , Clearside Biomedical (CLSD) , Coherus BioSciences (CHRS) , Gemphire Therapeutics (GEMP) and JetBlue Airways (JBLU) .

When did Patheon N.V. Ordinary shares, p IPO?

Patheon N.V. Ordinary shares, p (PTHN) raised $625 million in an initial public offering (IPO) on Thursday, July 21st 2016. The company issued 30,500,000 shares at $19.00-$22.00 per share. J.P. Morgan, Morgan Stanley, Jefferies, UBS Investment Bank, Credit Suisse, Evercore ISI and Wells Fargo Securities acted as the underwriters for the IPO and Baird, Piper Jaffray, Raymond James, William Blair, KeyBanc Capital Markets and Leerink Partners were co-managers.

NYSE:PTHN

Patheon N.V. Ordinary shares, p (PTHN) Stock Price, News & Analysis

→ Uncover this 2024 Hidden Gem (From Tips4Traders) (Ad)

Free PTHN Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $34.98
▼
$34.98
50-Day Range: N/A
52-Week Range: $23.72
▼
$35.13

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Patheon N.V. Ordinary shares, p alerts:

Ad DTI

Special FREE offer on stock hotsheets

These sheets tell you the exact day you should consider buying a stock… And the exact day you should consider selling it… All based on TEN YEARS of historic data and trends. For example, like January 6th through the 12th with Apple… It’s gone up every single year for the last decade. Or like May 26th through June 11th with LULU… Again - it’s gone up every single year for the last decade. Then there’s July 1st through the 21st with Walmart… What happened to WMT?

Click here and I’ll show you

About Patheon N.V. Ordinary shares, p Stock (NYSE:PTHN)

Patheon N.V. is a provider of outsourced pharmaceutical development and manufacturing services. The Company's segments include Drug Product Services (DPS), Pharmaceutical Development Services (PDS) and Drug Substance Services (DSS). The DPS segment is engaged in manufacturing and packaging for approved prescription, over-the-counter (OTC) and nutritional products. The PDS segment provides a range of formulation, production and technical services from the early stages of a product's development to regulatory approval, as well as for new formulations of approved products for lifecycle extension. The DSS segment provides small molecule active pharmaceutical ingredient (API) and outsourced manufacturing solutions for large molecule biological API from early development through commercial scale production. It provides an integrated range of API and finished drug product services to its customers, from formulation development to clinical and commercial-scale manufacturing.

Ad DTI

Special FREE offer on stock hotsheets

Click here and I’ll show you

PTHN Stock News Headlines

April 15, 2024 | money.usnews.com

Cloudflare Inc - Ordinary Shares - Class A

March 19, 2024 | money.usnews.com

Chain Bridge I - Ordinary Shares - Class A

April 18, 2024 | Darwin (Ad)

2024's Must-Have Guide: Master Crypto Investment Today

The cryptocurrency revolution is here with Bitcoin soaring past the $70,000 milestone—a clear indicator of the booming digital currency market. Are you prepared to navigate these exciting yet complex waters? Introducing "Navigating the Future: A Comprehensive Guide to Cryptocurrency Investments in 2024." This free digital guide is your essential resource for understanding and capitalizing on cryptocurrency investments, tailored for both newcomers and seasoned investors. (**By clicking the link you are subscribing to The Conservative Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)

February 28, 2024 | nasdaq.com

Yandex N.V. Class A Ordinary Shares (YNDX)

February 27, 2024 | money.usnews.com

Aon plc. - Ordinary Shares - Class A

February 23, 2024 | morningstar.com

The Kingfish Co NV Ordinary Shares KING

February 21, 2024 | money.usnews.com

Kinder Morgan Inc - Ordinary Shares - Class P

February 14, 2024 | morningstar.com

JDE Peets NV Ordinary Shares

April 18, 2024 | Darwin (Ad)

2024's Must-Have Guide: Master Crypto Investment Today

December 12, 2023 | nasdaq.com

Eaton Corporation, PLC Ordinary Shares (ETN)

December 2, 2023 | morningstar.com

Iveco Group NV Ordinary Shares

November 14, 2023 | finance.yahoo.com

Patheon N.V. Ordinary shares, p (PTHN)

November 13, 2023 | lse.co.uk

Ease2pay Nv Share Price (EAS2P.AM)

November 11, 2023 | lse.co.uk

New Amsterdam Invest N.v. Ordinary Shares Share Chat

October 29, 2023 | morningstar.com

InPoint Commercial Real Estate Income Inc Ordinary Shares - Class P

September 28, 2023 | morningstar.com

Wallbox NV Class A Ordinary Share

September 1, 2023 | money.usnews.com

Crowdstrike Holdings Inc - Ordinary Shares - Class A

August 16, 2023 | money.usnews.com

XPEL Inc - Ordinary Shares - Reg S

August 15, 2023 | morningstar.com

CureVac NV Ordinary Shares

August 4, 2023 | health.usnews.com

Keesha P. Kaplan

July 31, 2023 | nasdaq.com

Lifezone Metals Limited Ordinary Shares (LZM)

July 21, 2023 | uk.investing.com

FT Ordinary Share (FTII)

July 19, 2023 | nasdaq.com

NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)

June 28, 2023 | money.usnews.com

Comcast Corp - Ordinary Shares - Class A

June 19, 2023 | finance.yahoo.com

Improved Earnings Required Before RoodMicrotec N.V. (AMS:ROOD) Shares Find Their Feet

April 29, 2023 | morningstar.com

ZhongAn Online P&C Insurance Co Ltd Ordinary Shares - Class H

April 4, 2023 | thestreet.com

S&P, Moody's Shares Surge on Fraud Lawsuit Settlement

See More Headlines

Receive PTHN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Patheon N.V. Ordinary shares, p and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 6/08/2017
Today: 4/18/2024
Fiscal Year End: 10/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NYSE:PTHN
Previous Symbol: NASDAQ:PTHN
CUSIP: N/A
CIK: 1643848
Web: www.patheon.com
Phone: 31-20-622-3243
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Paul S. Levy
Chairman of the Board
James C. Mullen
Chief Executive Officer, Director
Stuart R. Grant
Chief Financial Officer, Executive Vice President
Gilles A. Cottier
President - Global Pharmaceutical Development Services
Franco Negron
President - Drug Product Services
Lukas Utiger
President - Drug Substance
Michael J. Lehmann
Executive Vice President - Global Sales and Marketing
Michael E. Lytton J.D.
Executive Vice President - Corporate Development and Strategy
Rebecca Holland New
Chief Human Resources Officer and Executive Vice President - Communications and Project Management Office
Harry R. Gill III
Senior Vice President - Quality and Continuous Improvement

Key Competitors

View All Competitors

PTHN Stock Analysis - Frequently Asked Questions

How were Patheon N.V. Ordinary shares, p's earnings last quarter?: Patheon N.V. Ordinary shares, p (NYSE:PTHN) announced its earnings results on Thursday, June, 8th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.01. The company had revenue of $483.40 million for the quarter, compared to the consensus estimate of $466.08 million. The firm's quarterly revenue was up 3.2% on a year-over-year basis.
What other stocks do shareholders of Patheon N.V. Ordinary shares, p own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Patheon N.V. Ordinary shares, p investors own include SVB Financial Group (SIVB), Skyworks Solutions (SWKS), Wells Fargo & Company (WFC), Alexion Pharmaceuticals (ALXN), NXP Semiconductors (NXPI), Bank of the Ozarks (OZRK), Clearside Biomedical (CLSD), Coherus BioSciences (CHRS), Gemphire Therapeutics (GEMP) and JetBlue Airways (JBLU).
When did Patheon N.V. Ordinary shares, p IPO?: Patheon N.V. Ordinary shares, p (PTHN) raised $625 million in an initial public offering (IPO) on Thursday, July 21st 2016. The company issued 30,500,000 shares at $19.00-$22.00 per share. J.P. Morgan, Morgan Stanley, Jefferies, UBS Investment Bank, Credit Suisse, Evercore ISI and Wells Fargo Securities acted as the underwriters for the IPO and Baird, Piper Jaffray, Raymond James, William Blair, KeyBanc Capital Markets and Leerink Partners were co-managers.

This page (NYSE:PTHN) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Patheon N.V. Ordinary shares, p (PTHN) Stock Price, News & Analysis

About Patheon N.V. Ordinary shares, p Stock (NYSE:PTHN)

PTHN Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

PTHN Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info